Tian‐Yue Li

ORCID: 0000-0001-5930-2757
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver physiology and pathology
  • Glycosylation and Glycoproteins Research
  • Cancer Research and Treatments
  • Ubiquitin and proteasome pathways
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Regulation of Appetite and Obesity
  • Lung Cancer Treatments and Mutations
  • Dietary Effects on Health
  • Diet and metabolism studies

China Medical University
2024

Kunming Medical University
2020-2024

Peking University Cancer Hospital
2024

Peking University
2024

The combination of anti-angiogenesis agents with immune-checkpoint inhibitors is a promising treatment for patients advanced hepatocellular carcinoma (HCC); however, therapeutic resistance caused by cancer stem cells present in tumor microenvironments remains to be overcome. In this study, we report the first time that Kringle 1 domain human hepatocyte growth-factor α chain (HGFK1), previously described peptide, repressed sub-population CD90+ (CSCs) and promoted their differentiation...

10.3390/ph17050645 article EN cc-by Pharmaceuticals 2024-05-16

Cocaine abuse has been strongly linked to blood-brain barrier (BBB) dysfunction, though the exact mechanism by which cocaine disrupts BBB remains unclear. In this study, we found that treatment reduces expression of glucose transporter 1 (GLUT1) in brain microvascular endothelial cells, a key factor cocaine-induced uptake, leakage, and cognitive impairment. Mechanistically, our results show upregulates miR-320a, turn suppresses GLUT1 via beta 2-adrenergic receptor (ADRB2). Notably,...

10.1111/jpi.70002 article EN Journal of Pineal Research 2024-11-13
Coming Soon ...